These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19996695)

  • 1. Influence of growth conditions on plasmid DNA production.
    Silva F; Passarinha L; Sousa F; Queiroz JA; Domingues FC
    J Microbiol Biotechnol; 2009 Nov; 19(11):1408-14. PubMed ID: 19996695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth medium selection and its economic impact on plasmid DNA production.
    Danquah MK; Forde GM
    J Biosci Bioeng; 2007 Dec; 104(6):490-7. PubMed ID: 18215636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
    Phue JN; Lee SJ; Trinh L; Shiloach J
    Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production.
    Munguía-Soto R; García-Rendón A; Garibay-Escobar A; Guerrero-Germán P; Tejeda-Mansir A
    Biotechnol Appl Biochem; 2015; 62(6):795-805. PubMed ID: 25556882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated fed-batch fermentation with feed-back controls based on dissolved oxygen (DO) and pH for production of DNA vaccines.
    Chen W; Graham C; Ciccarelli RB
    J Ind Microbiol Biotechnol; 1997 Jan; 18(1):43-8. PubMed ID: 9079287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fermentation strategy on the characteristics of plasmid DNA production.
    O'Kennedy RD; Ward JM; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2003 Feb; 37(Pt 1):83-90. PubMed ID: 12578555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
    Ramírez EA; Velázquez D; Lara AR
    Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
    Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
    Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
    Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
    Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
    Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
    J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible Escherichia coli fermentation for increased plasmid DNA production.
    Carnes AE; Hodgson CP; Williams JA
    Biotechnol Appl Biochem; 2006 Nov; 45(Pt 3):155-66. PubMed ID: 16819941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new plasmid DNA vaccine vectors with R1-based replicons.
    Bower DM; Prather KL
    Microb Cell Fact; 2012 Aug; 11():107. PubMed ID: 22889338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid DNA fermentation strategies: influence on plasmid stability and cell physiology.
    Silva F; Queiroz JA; Domingues FC
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2571-80. PubMed ID: 22089386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing strategies to increase plasmid DNA production in Escherichia coli DH5α using batch culture.
    Islas-Lugo F; Vega-Estrada J; Alvis CA; Ortega-López J; Del Carmen Montes-Horcasitas M
    J Biotechnol; 2016 Sep; 233():66-73. PubMed ID: 27374404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of amino acids in the amplification and quality of DNA vectors for industrial applications.
    Dorward A; O'Kennedy RD; Folarin O; Ward JM; Keshavarz-Moore E
    Biotechnol Prog; 2019 Nov; 35(6):e2883. PubMed ID: 31298810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial growth medium that significantly increases the yield of recombinant plasmid.
    Duttweiler HM; Gross DS
    Biotechniques; 1998 Mar; 24(3):438-44. PubMed ID: 9526655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Biosynthesis of Plasmid DNA from Escherichia coli Applying Experimental Design.
    Passarinha LA
    Methods Mol Biol; 2021; 2197():135-150. PubMed ID: 32827135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultivation of E. coli carrying a plasmid-based Measles vaccine construct (4.2 kbp pcDNA3F) employing medium optimisation and pH-temperature induction techniques.
    Ongkudon CM; Pickering R; Webster D; Danquah MK
    Microb Cell Fact; 2011 Mar; 10():16. PubMed ID: 21375765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of plasmid DNA yields during fed-batch culture of a fruR-knockout Escherichia coli strain.
    Ow DS; Yap MG; Oh SK
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):53-9. PubMed ID: 18380624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.